Crispr Therapeutics shares owned by Leavell Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Leavell Investment Management
from 13F filings
Historical chart of Leavell Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Leavell Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Leavell Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.5M | 23k | 64.81 |
| 2025-06-30 | $865k | 18k | 48.64 |
| 2025-03-31 | $340k | 10k | 34.03 |
| 2024-09-30 | $268k | 5.7k | 46.98 |
| 2024-06-30 | $683k | 13k | 53.99 |
| 2024-03-31 | $716k | 11k | 68.19 |
| 2023-12-31 | $657k | 11k | 62.57 |
| 2023-09-30 | $277k | 6.1k | 45.41 |
More positions owned by Leavell Investment Management
View all positions for Leavell Investment Management